The Right to Try Bill and Stem Cell Therapy!

Posted on September 21, 2018 by:

This year in 2018 the “Right to Try Bill” was passed. This bill allows patients in the US to seek and obtain non-FDA approved treatment here on US territory. This means a door has been opened for stem cell therapy. Stem cell therapy can now be given to a patient with chronic conditions in the US under this Bill but have to follow the following guidelines.

Stem cell treatments that are not FDA approved can now be administered. However, the patient must be shown and told these procedures are not approved. Many areas of stem cell therapy are not approved. Even if a patient is receiving these under the bill we do not know the true efficacy of the treatment. For instance today in 2018 we do not know if stem cell therapy
will treat MS. However, we do no it is a safe treatment and by far the potential benefit outweighs the risk.

This bill will allow patients with COPD, MS, Alzheimer’s, and other degenerative diseases access to stem cell therapy here on US soil. They can now obtain the care under US physicians guidance and help achieve maximum care.

At our state of the art facility, MetroMD has provided over 1000 cell-based cases to date. The quality and efficacy of these treatments is always the highest priority of MetroMD. We always aim to give our patients the best treatments available and our goal is to improve their quality of life.

MetroMD was established in 2009 and was opened to provide this high quality of care procedures. Head physician Dr. Martin, stem cell biologist Devin Stone and Hollywood Presbyterian hospital put their efforts together to open this clinic and provide services to the community and world alike.

Click here for more information on Stem Cell Thearpy!

©MetroMD2017 | Sitemap | Privacy Policy